Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$13,401,234
+$1,364,031 QoQ
Shares Held
52,767
+7.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#942
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gladstone Institutional Advisory LLC holds $67,973,516 across 11 Drug Manufacturers - General names. JNJ ranks #2 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
19,736 | $23,671,952 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
52,767 | $13,401,234 | |
| 3 | MRK |
Merck & Co., Inc.
|
84,891 | $10,908,493 | |
| 4 | ABBV |
AbbVie Inc.
|
33,122 | $8,334,820 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
67,905 | $3,912,686 | |
| 6 | AMGN |
Amgen Inc
|
6,692 | $2,423,307 | |
| 7 | PFE |
Pfizer Inc
|
78,104 | $1,880,744 | |
| 8 | NVS |
Novartis AG
|
8,936 | $1,400,449 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,401,234 | 52,767 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $12,037,203 | 49,244 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,380,818 | 50,161 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,758,840 | 52,631 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $8,265,913 | 54,114 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,909,090 | 53,721 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,874,800 | 47,537 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $8,581,239 | 52,951 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $7,821,898 | 53,516 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $8,220,343 | 51,965 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,162,704 | 45,698 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,230,070 | 46,421 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,623,260 | 52,098 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $13,019,070 | 83,994 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,004,588 | 62,296 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $10,293,803 | 63,013 | Shares | Sole | 2023-01-30 | |
| 2022-06-30 | $10,727,994 | 60,436 | Shares | Sole | 2023-01-30 | |
| 2022-03-31 | $10,019,698 | 56,535 | Shares | Sole | 2023-01-30 | |
| 2021-12-31 | $8,373,705 | 48,949 | Shares | Sole | 2023-01-30 | |
| 2021-09-30 | $6,372,951 | 39,461 | Shares | Sole | 2023-01-30 | |
| 2021-06-30 | $4,926,220 | 29,903 | Shares | Sole | 2023-01-30 | |
| 2021-03-31 | $2,379,294 | 14,477 | Shares | Sole | 2023-01-30 | |
| 2020-12-31 | $1,675,939 | 10,649 | Shares | Sole | 2023-01-30 | |
| 2020-09-30 | $1,214,116 | 8,155 | Shares | Sole | 2023-01-30 | |
| 2020-06-30 | $1,122,086 | 7,979 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,387,223 | 10,579 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||